Life Sciences

Oct 14, 2026

Likang to Present AI Cancer Immunotherapy Platform in Abu Dhabi

Likang Life Sciences will present its AI based neoantigen discovery platform at the Abu Dhabi Future Health Summit 2026, held October 20 to 22.

Oct 14, 2026

INmune Bio and QCi Apply Quantum Computing to XPro Research

INmune Bio and Quantum Computing Inc. will use quantum optimization, AI and data analytics to identify potential disease indications and biomarkers for the investigational treatment XPro.

Oct 14, 2026

WeInfuse and Clarion Connect AI Agents to Infusion Workflows

WeInfuse and Clarion have partnered to connect AI agents with infusion and pharmacy data. The agents handle routine patient calls using current order, authorization and appointment information.

Oct 14, 2026

Illumina Launches BioInsight Platform for Genomic Research

Illumina launched a unified software environment that combines genomic analysis applications, AI models and curated biological data.

Oct 14, 2026

PhaseV Validates GLP-1 Adverse Event Model on Patient Data

PhaseV says its causal model predicted weight changes, adverse events and treatment dropout among patients taking GLP-1 and related incretin medications.

Oct 14, 2026

TRI adds AI risk assessment to OPRA clinical trial platform

OPRA 26.2 adds an AI agent that analyzes clinical trial protocols and drafts risk assessments for human review.

Oct 13, 2026

Suvoda Expands Sofia to All New RTSM and eCOA Trials

Suvoda is making its Sofia AI assistant, which can take authorized system actions with an audit trail, available for all new trials using its RTSM/IRT or eCOA products.

Oct 13, 2026

HealthpointCapital Invests in Surgical Software Company Ospitek

HealthpointCapital has made a significant investment in Ospitek, which provides AI software for surgical operations and patient flow. Financial terms were not disclosed.

Oct 13, 2026

Prologue Medicines names Stephen Harrison chief scientific officer

Stephen Harrison will direct Prologue Medicines' scientific strategy and the development of its DELVE machine learning platform and drug pipeline.

Oct 13, 2026

symplr Survey Finds Nearly Half of Hospital Operations Remain Manual

A symplr survey found that 40% to 46% of healthcare professionals consider core hospital processes fully manual, while respondents spend an average of 86 minutes each day on administrative tasks they believe AI could reduce.

Oct 13, 2026

MediRoutes Launches Predictive ETAs for Medical Transport

MediRoutes launched a predictive arrival time feature that uses GPS trip history, machine learning and live traffic data to help medical transport providers build schedules.

Oct 13, 2026

Medsender Launches Agentic Referral Management for Specialty Practices

Medsender launched software that processes incoming referrals, contacts patients and adds booked appointments to electronic health records.

Oct 13, 2026

Sensydia Raises More Than $6 Million for AI Cardiac System

Sensydia secured more than $6 million to complete a clinical study of its Cardiac Performance System and prepare for a commercial launch.

Oct 13, 2026

Red Queen Bio Names Ian Watson Chief Government Affairs Officer

Red Queen Bio appointed Ian Watson as chief government affairs officer to lead its federal engagement strategy. Watson previously held senior biodefense and biosecurity roles across several US agencies.

Oct 13, 2026

TRI Launches TRIAL.OS for Clinical Trial Management

TRIAL.OS provides AI assisted applications for clinical trial analysis, risk identification and recommended actions.

Oct 12, 2026

ADLM to Brief Congress on Healthcare AI Policy

ADLM will hold a congressional briefing on October 13 about oversight and regulation for AI used in healthcare and laboratory medicine.

Oct 12, 2026

Function Brings Lab Results to Google Health App

US users will be able to share Function lab results with the Google Health app later this fall, combining biomarker data with wearable metrics and AI coaching.

Oct 12, 2026

DeepSight Technology Adds Scott Huennekens to Board

DeepSight Technology appointed former Volcano and Verb Surgical CEO Scott Huennekens to its board following the completion of a Series C financing.

Oct 12, 2026

Flo Health Partners With Google Health on Wearables and Women's Health AI

Flo Health and Google Health will connect cycle insights with wearable data and develop AI models for women's health under a multi year partnership.

Oct 12, 2026

Immorta Bio completes preclinical studies of AI designed senolytic peptide

Immorta Bio completed planned preclinical studies of SenoMune-0257, a nine amino acid peptide designed to help the immune system eliminate senescent cells. The company plans initial human testing before the end of 2026.